Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27050608 | 0.90 | L3MBTL1 (0.41) | AVPR1AMAPK1HTTL3MBTL1KDM4E | |
| SCHEMBL22200016 | 0.88 | L3MBTL1 (0.42) | AVPR1AMAPK1HTTL3MBTL1KDM4E | |
| SCHEMBL12875745 | 0.86 | L3MBTL1 (0.46) | MAPK1HTTL3MBTL1KDM4EATM | |
| SCHEMBL27044141 | 0.86 | PIK3CA (0.35) | AVPR1AL3MBTL1 | |
| SCHEMBL24549928 | 0.86 | KMT2A (0.41) | AVPR1AMAPK1HTTL3MBTL1KDM4E | |
| SCHEMBL26420952 | 0.86 | KMT2A (0.41) | AVPR1AMAPK1HTTL3MBTL1KDM4E | |
| SCHEMBL26420941 | 0.86 | KMT2A (0.41) | AVPR1AMAPK1HTTL3MBTL1KDM4E | |
| SCHEMBL26420953 | 0.86 | KMT2A (0.41) | AVPR1AMAPK1HTTL3MBTL1KDM4E | |
| SCHEMBL17123113 | 0.85 | L3MBTL1 (0.44) | MAPK1HTTL3MBTL1KDM4EATM | |
| SCHEMBL14900857 | 0.85 | L3MBTL1 (0.44) | MAPK1HTTL3MBTL1KDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220173326-A1 | MELT MIXTURE FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2022-06-02 | — | — | US | disclosed |
| US-20180138420-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2018-05-17 | — | — | US | disclosed |
| US-20180138420-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180138420-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | EML4, LAGE3, KCNN4 | AVPR1A 4062/4885MAPK1 3409/4885HTT 688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.